Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Authors: Pierre Charles, Benjamin Terrier, Élodie Perrodeau, Pascal Cohen, Stanislas Faguer, Antoine Huart, M. Hamidou, C. Agard, Bernard Bonnotte, M. Samson, Alexandre Karras, Noémie Jourde‐Chiche, François Lifermann, P. Gobert, Catherine Hanrotel‐Saliou, Pascal Godmer, Nicolas Martin Silva, G. Pugnet, Marie Matignon, O. Aumaître, Jean‐François Viallard, F. Maurier, N. Méaux-Ruault, Sophie Rivière, Jean Sibilia, Xavier Puéchal, Philippe Ravaud, Luc Mouthon, Loı̈c Guillevin - Annals of the Rheumatic Diseases 2018 cited by 336